AI-driven ECG equipment – Transforming cardiac care in India

The electrocardiogram remains the most widely used cardiac diagnostic tool globally, yet the ECG equipment landscape is undergoing a profound transformation. The integration of artificial intelligence, portable form factors, and cloud-connected monitoring is reshaping how we detect, diagnose, and manage cardiac conditions. As a practising interventional cardiologist overseeing catheterization laboratories across multiple hospitals in the Metro Hospital Group, I witness daily how upgraded ECG infrastructure directly impacts clinical decision-making, triage efficiency, and ultimately patient outcomes in both emergency and elective settings.

The global AI ECG analysis market is projected to grow at a compound annual growth rate exceeding 27 per cent through 2031, driven by rising cardiovascular disease prevalence and the demand for remote patient monitoring. In India, where an estimated 100 million people live with heart conditions and access to trained cardiologists remains unevenly distributed across urban and rural settings, this growth carries particular significance. AI-powered ECG platforms are no longer futuristic aspirations; they are clinical necessities that can democratise high-quality cardiac diagnostics.

Several recent developments stand out. FDA-cleared platforms such as AccurECG 2.0 now offer device-agnostic AI interpretation capable of detecting conditions well beyond traditional arrhythmias, including aortic valve stenosis and hyperkalemia from a standard 12-lead tracing. AliveCor’s Kardia 12L system leverages AI to derive a full 12-lead ECG from a compact handheld device, now offering 39 validated algorithms. These innovations mean that a district hospital or a primary health centre can access diagnostic-grade ECG interpretation that was previously available only at tertiary cardiac centres with specialist manpower.

At Metro Hospital Group, our procurement strategy actively reflects this technological shift. We are evaluating AI-enabled 12-lead ECG systems that integrate seamlessly with our existing hospital information systems and electronic medical records. The key criteria driving our procurement decisions include real-time AI interpretation with physician-override capability, cloud connectivity for remote expert consultation, and seamless data integration with our catheterization laboratory imaging platforms such as intravascular OCT and FFR. Our goal is not merely equipment replacement but building an intelligent, connected cardiac diagnostic ecosystem that enhances clinical workflows from the emergency department to the cath lab.

The Indian market presents unique opportunities alongside significant challenges. Collaborations for AI-powered remote ECG diagnosis represent exactly the kind of innovation India needs, enabling rapid cardiac assessments in as little as ten seconds across homes and clinics, particularly in underserved regions. However, regulatory frameworks must keep pace with technological advancement. Globally, only a fraction of cleared AI medical devices are supported by randomised clinical trials, and Indian regulatory bodies must ensure that any AI ECG platform deployed at scale meets rigorous clinical validation standards before widespread adoption.

Wearable ECG technology represents another exciting frontier. Smartwatch-based single-lead ECGs and credit-card-sized personal monitoring devices are empowering patients with real-time cardiac data. For cardiologists, this heralds a paradigm shift from episodic clinic-based ECG recordings to continuous ambulatory data streams that capture arrhythmias and ischaemic events as they occur. Integrating these wearable data feeds into hospital information systems will be the next significant procurement and infrastructure challenge that forward-thinking hospitals must prepare for.

Looking ahead, the convergence of AI-powered interpretation, portable hardware, cloud connectivity, and wearable integration will define the next generation of ECG equipment. Indian hospitals that invest strategically in these technologies today will be far better positioned to deliver timely, accurate, and equitable cardiac care to the populations that need it most. The ECG is no longer just a tracing on paper; it is becoming an intelligent gateway to comprehensive cardiac management.

The author is Senior Interventional Cardiologist & Group Director, Cardiac Cath Lab, Metro Hospital Group.